Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05505110 · ClinicalTrials.gov registry record · Early Phase 1
MOdification Of THe Early-Life Respiratory Microbiome Through Vaginal SEEDing
A Early Phase 1 study of Microbiome and C-section, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05505110 is a Early Phase 1 study of Microbiome and C-section that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 20 participants, below the 141-participant average among 12 other Microbiome trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05505110, a Early Phase 1 study of Microbiome and C-section, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center, parallel-arm, blind, sham-controlled, feasibility randomized controlled trial (RCT) to be conducted in healthy cesarean-born children. Eligible children will be randomized 1:1 to have their nose swabbed with either maternal vaginal secretions or a sterile swab (intervention vs. control group, respectively). The main hypothesis is that conducting an RCT assessing the utility of vaginal seeding in modifying the early-life upper respiratory tract (URT) microbiome of children born by cesarean section (C-section) is feasible and that the intervention is safe.
Conditions Studied
Interventions
- BIOLOGICAL Vaginal Seeding
- OTHER Sterile Swab
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-11-09 |
| Est. Completion | 2028-08-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05505110
The ClinicalTrials.gov registry entry for NCT05505110 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 141-participant average among 12 other Microbiome trials with a reported enrollment target (86% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Microbiome appearing as the primary indexed condition, and to 2 interventions - of which Vaginal Seeding is the first listed.
NCT05505110 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT05505110 about?
NCT05505110 is a clinical study titled "MOdification Of THe Early-Life Respiratory Microbiome Through Vaginal SEEDing". This is a single-center, parallel-arm, blind, sham-controlled, feasibility randomized controlled trial (RCT) to be conducted in healthy cesarean-born children. Eligible children will be randomized 1:1 to have their nose swabbed with either maternal vaginal secretions or a sterile swab (intervention ...
What is the current status of trial NCT05505110?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2022-11-09. Estimated completion is 2028-08-10.
What conditions does trial NCT05505110 study?
This clinical trial studies the following conditions: Microbiome, C-section, Vaginal Seeding, Respiratory.
What interventions are being tested in trial NCT05505110?
The interventions under investigation include: Vaginal Seeding (BIOLOGICAL), Sterile Swab (OTHER).
Who is sponsoring clinical trial NCT05505110?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05505110 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Microbiome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Flourish: Exploring the Early Infant Gut Microbiome
RECRUITING · NA
-
The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma
RECRUITING
-
Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
RECRUITING · Phase 2
-
Infant Restore: Efficacy of Microbiome Analysis and Education
ACTIVE NOT RECRUITING · NA
-
IGNITE Firefighters' Health
ACTIVE NOT RECRUITING · NA
-
Alcoholic Liver Disease and the Gut Microbiome
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.